The Hindu

Strides gets USFDA nod for liver disease drug


Strides Pharma Science said its step-down subsidiary has received approval from the U.S. health regulator to market Ursodiol tablets, used for treatment of patients with primary biliary cirrhosis. Strides Pharma Global, Singapore, has received approval for Ursodiol tablets USP in the strengths of 250 mg and 500 mg from the United States Food and Drug Administra­tion (USFDA).

Newspapers in English

Newspapers from India